Testosterone administration promotes regeneration of chemically impaired spermatogenesis in rats

International Journal of Urology

Volumn 13, Issue 8, 2006, Pages 1103-1108

  Udagawa, Koichi ^a   Ogawa, Takehiko ^a   Watanabe, Takeshi ^a   Tamura, Yoichi ^a   Kita, Kaoru ^a   Kubota, Yoshinobu ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Busulfan; Chemotherapy; Rat; Spermatogenesis; Testosterone

Indexed keywords

BUSULFAN; TESTOSTERONE ENANTATE;

ANDROGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL REGENERATION; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; CONVALESCENCE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; SEMINIFEROUS TUBULE; SPECIES COMPARISON; SPERMATID; SPERMATOGENESIS; SPERMATOZOON COUNT; TESTIS INJURY; THERAPY EFFECT; TISSUE SECTION; TREATMENT OUTCOME;

ANIMALS; BUSULFAN; GONADOTROPIN-RELEASING HORMONE; INFERTILITY, MALE; MALE; RATS; RATS, INBRED F344; REGENERATION; SPERMATIDS; SPERMATOGENESIS; TESTIS; TESTOSTERONE;

EID: 33746391982     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2006.01484.x     Document Type: Article

References (24)

1. Schrader M, Muller M, Straub B, Miller K. The impact of chemotherapy on male fertility: a survey of the biologic basis and clinical aspects. Reprod. Toxicol. 2001; 15: 611-27.
2. Meistrich ML. Hormonal stimulation of the recovery of spermatogenesis following chemo- or radiotherapy. Review article. APMIS 1998; 106: 37-45.
3. Meistrich ML, Kangasniemi M. Hormone treatment after irradiation stimulates recovery of rat spermatogenesis from surviving spermatogonia. J. Androl. 1997; 18: 80-7.
4. Udagawa K, Ogawa T, Watanabe T, Yumura Y, Takeda M, Hosaka M. GnRH analog, leuprorelin acetate, promotes regeneration of rat spermatogenesis after severe chemical damage. Int. J. Urol. 2001; 8: 615-22.
5. Walsh PC, Swerdloff RS. Biphasic effect of testosterone on spermatogenesis in the rat. Invest. Urol. 1973; 11: 190-3.
6. Bucci LR, Meistrich ML. Effects of busulfan on murine spermatogenesis: cytotoxicity, sterility, sperm abnormalities, and dominant lethal mutations. Mutat. Res. 1987; 176: 259-68.
7. Lewis-Johnes DI, Kerrigan DD. A modified Johnsen's count for evaluation of spermatogenesis in the rat. IRCS Med. Sci. 1985; 13: 510-11.
8. Udagawa K, Takeda M, Hosaka M, Kubota Y, Ogawa T. Recovery of spermatogenesis by high dose gonadotropin-releasing hormone analogue treatment in rat cryptorchid testis after orchiopexy. J. Urol. 2002; 168: 1279-83.
9. Meistrich ML, van Beek MEAB. Spermatogonial stem cells: assessing their survival and ability to produce differentiated cells. In: Chapin RE, Heindel J (eds). Methods in Reproductive Toxicology, 3A. Academic Press, New York, 1993; 106-23.
10. Shetty G, Wilson G, Huhtaniemi I, Shuttlesworth GA, Reissmann T, Meistrich ML. Gonadotropin-releasing hormone analogs stimulate and testosterone inhibits the recovery of spermatogenesis in irradiated rats. Endocrinology 2000; 141: 1735-45.
11. Shuttlesworth GA, De Rooij DG, Huhtaniemi I et al. Enhancement of A spermatogonial proliferation and differentiation in irradiated rats by gonadotropin-releasing hormone antagonist administration. Endocrinology 2000; 141: 37-49.
12. Shetty G, Wilson G, Hardy MP, Niu E, Huhtaniemi I, Meistrich ML. Inhibition of recovery of spermatogenesis in irradiated rats by different androgens. Endocrinology 2002; 143: 3385-96.
13. Meistrich ML, Shetty G. Suppression of testosterone stimulates recovery of spermatogenesis after cancer treatment. Int. J. Androl. 2003; 26: 141-6.
14. Bergh A, Damber J-E. Vascular control in testicular physiology. In: De Kretser D (ed.). Molecular Biology of the Male Reproductive System. Academic Press Inc., San Diego, 1993; 439-68.
15. Ogawa T, Dobrinski I, Avarbock MR, Brinster RL. Leuprolide, a gonadotropin-releasing hormone agonist, enhances colonization after spermatogonial transplantation into mouse testes. Tissue Cell 1998; 30: 583-8.
16. Ogawa T, Dobrinbki I, Brinster RL. Recipient preparation is critical for spermatogonial transplantation in the rat. Tissue Cell 1999; 31: 461-72.
17. Ohmura N, Ogawa T, Ono M et al. Increment of murine spermatogonial cell number by gonadotropin-releasing hormone analogue is independent of stem cell factor-c-kit signal. Biol. Reprod. 2003; 68: 2304-13.
18. Heller CG, Nelson WO, Hill IB et al. Improvement in spermatogenesis following depression of the human testis with testosterone. Fertil. Steril. 1950; 1: 415-22.
19. Ludwig DJ. The effect of androgen on spermatogenesis. Endocrinology 1950; 46: 453-81.
20. Ralf C, Nieschlag E. Potential adverse effects of long-term testosterone therapy. Baillieres Clin. Endocrinol. Metab. 1998; 12: 521-34.
21. Winters SJ. Current status of testosterone replacement therapy in men. Arch. Fam. Med. 1999; 8: 257-63.
22. Wilson JD. Androgens. In: Gilman AG, Rall TW, Nies AS et al. (eds). Goodman and Gilman's the Pharmacological Basis of Therapeutics, 8th edn. Pergamon Press, New York, 1990; 1413-30.
23. Anderson RA, Wu FCW. Comparison between testosterone enanthate-induced azoospermia and oligospermia in a male contraceptive study. II. Pharmacokinetics and pharmacodynamics of once weekly administration of testosterone enanthate. J. Clin. Endocrinol. Metab. 1996; 81: 896-901.
24. Freireich EJ, Gehan EA, Rall DP, Schmidt LH, Skipper HE. Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey and man. Cancer Chemother. Rep. 1966; 50: 219-44.